AR036533A1 - Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos - Google Patents

Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos

Info

Publication number
AR036533A1
AR036533A1 ARP020103490A ARP020103490A AR036533A1 AR 036533 A1 AR036533 A1 AR 036533A1 AR P020103490 A ARP020103490 A AR P020103490A AR P020103490 A ARP020103490 A AR P020103490A AR 036533 A1 AR036533 A1 AR 036533A1
Authority
AR
Argentina
Prior art keywords
alkyl
compounds
cycloalkyl
hydrogen
urea
Prior art date
Application number
ARP020103490A
Other languages
English (en)
Spanish (es)
Inventor
Paula Nanette Belloni
Denis John Kertesz
Michael Klaus
Jean-Marc Lapierre
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR036533A1 publication Critical patent/AR036533A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP020103490A 2001-09-18 2002-09-16 Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos AR036533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32296301P 2001-09-18 2001-09-18

Publications (1)

Publication Number Publication Date
AR036533A1 true AR036533A1 (es) 2004-09-15

Family

ID=33130243

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103490A AR036533A1 (es) 2001-09-18 2002-09-16 Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos

Country Status (13)

Country Link
US (1) US6844466B2 (https=)
EP (1) EP1430024A1 (https=)
JP (1) JP4421293B2 (https=)
KR (1) KR100896550B1 (https=)
CN (1) CN1283621C (https=)
AR (1) AR036533A1 (https=)
AU (1) AU2002329276B2 (https=)
BR (1) BR0212583A (https=)
CA (1) CA2460693C (https=)
MX (1) MXPA04002590A (https=)
PL (1) PL370361A1 (https=)
RU (1) RU2299877C2 (https=)
WO (1) WO2003024921A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2530581A1 (en) * 2003-06-23 2005-01-06 Auspex Pharmaceuticals Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
WO2005108338A1 (en) * 2004-05-03 2005-11-17 Auspex Pharmaceuticals Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
US7803951B2 (en) * 2005-03-30 2010-09-28 Merck Sharp & Dohme Corp. Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
TW200821284A (en) * 2006-10-03 2008-05-16 Merck & Co Inc Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
EP4066826B1 (en) 2010-09-01 2024-03-06 Thomas Jefferson University Retinoic acid receptor gamma agonists for muscle repair and regeneration
CA2890424C (en) 2012-11-08 2020-11-17 Yamaguchi University Therapeutic agent for keratoconjunctive disorders
KR101426197B1 (ko) * 2013-02-20 2014-08-01 여윤영 주먹밥틀
RS58045B1 (sr) 2013-05-22 2019-02-28 Univ Yamaguchi Inhibitor za retinohoroidalne poremećaje
CN105294567B (zh) * 2015-10-29 2018-10-09 湖北新烯王生物科技有限公司 取代的3-氟苯基甲醇类化合物、药物组合物及用途
SG11201810658PA (en) 2016-06-08 2018-12-28 Clementia Pharmaceuticals Inc Methods for treating heterotopic ossification
MX379489B (es) 2016-11-16 2025-03-11 Clementia Pharmaceuticals Inc Metodos para tratar la osteocondromatosis multiple (mo).

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
DE10199033I2 (de) * 1992-04-22 2003-01-09 Ligand Parmaceuticals Inc Retinoid-x Rezeptor selektive Verbindungen
US6093742A (en) 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists

Also Published As

Publication number Publication date
KR20040035809A (ko) 2004-04-29
PL370361A1 (en) 2005-05-16
MXPA04002590A (es) 2004-06-18
EP1430024A1 (en) 2004-06-23
CN1283621C (zh) 2006-11-08
RU2004111787A (ru) 2005-10-20
US6844466B2 (en) 2005-01-18
CN1555359A (zh) 2004-12-15
KR100896550B1 (ko) 2009-05-07
CA2460693C (en) 2010-12-07
RU2299877C2 (ru) 2007-05-27
CA2460693A1 (en) 2003-03-27
BR0212583A (pt) 2004-10-13
JP2005505571A (ja) 2005-02-24
JP4421293B2 (ja) 2010-02-24
WO2003024921A1 (en) 2003-03-27
US20030158226A1 (en) 2003-08-21
AU2002329276B2 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
DOP2002000333A (es) Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz
DE60335869D1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
AR036659A1 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
ECSP034691A (es) Inhibidores de piridina de metaloproteinasas de la matriz
CO5251381A1 (es) Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen
AR036533A1 (es) Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos
DE69522945D1 (de) Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind
AR041566A1 (es) Derivados de indol utiles para el tratamiento de enfermedades
CA2497868A1 (en) Heterocyclic compounds
ATE297910T1 (de) Retinoid x rezeptormodulatoren
AR066972A1 (es) Derivados azapeptidicos
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
ECSP034831A (es) Derivados sustituidos de la 2-piridina ciclohexano-1,4-diamina
BRPI0409229A (pt) inibidores das fosfodiesterases na infertilidade
DOP2002000328A (es) Pirimidinas inhibidoras de metaloproteinasas de matriz
ATE280763T1 (de) Matrix-metalloproteinase-hemmer
DK1506203T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoger deraf og anvendelser deraf
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
AR033793A1 (es) Compuestos derivados del benceno, su utilizacion, procedimientos para su preparacion y composiciones farmaceuticas que los contienen
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
NO20071321L (no) Anti-inflammatoriske midler
DE60014394D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
DE602004026558D1 (de) Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren
AR054707A1 (es) Derivados de octahidropirrolo 3,4-c pirrol, un procedimiento para su preparacion, una composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento